Proceedings of the National Academy of Sciences · 2000 · 128 citations · 30 references
Chronic beryllium disease results from beryllium exposure in the workplace and is characterized by CD4(+) T cell-mediated inflammation in the lung. Susceptibility to this disease is associated with particular HLA-DP alleles. We isolated beryllium-specific T cell lines from the lungs of affected patients. These CD4(+) T cell lines specifically responded to beryllium in culture in the presence of antigen-presenting cells that expressed class II MHC molecules HLA-DR, -DQ, and -DP. The response to beryllium was nearly completely and selectively blocked by mAb to HLA-DP. Additional studies showed that only certain HLA-DP alleles allowed presentation of beryllium. Overall, the DP alleles that presented beryllium to disease-specific T cell lines match those implicated in disease susceptibility, providing a mechanism for this association. Based on amino acid residues shared by these restricting and susceptibility DP alleles, our results provide insight into the residues of the DP beta-chain required for beryllium presentation.
30
A Molecular Basis for MHC Class II—Associated Autoimmunity
John A. Todd, Hans Acha‐Orbea, John I. Bell et al. · Science · 1988 · 708 citations
Renuka Uppaluri, Eric A. Hoffman, Milan Sonka et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 563 citations
HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium Disease
Luca Richeldi, Rosa Sorrentino, Cesare Saltini · Science · 1993 · 449 citations
Detection of a novel human class II HLA antigen
Andrew J. Watson, Robert DeMars, Ian S. Trowbridge et al. · Nature · 1983 · 382 citations